Your shopping cart is currently empty

MRIA9, an ATP-competitive inhibitor targeting pan Salt-Inducible Kinases (SIK) and PAK2/3, demonstrates IC50 values of 516 nM, 180 nM, and 127 nM for SIK1, SIK2, and SIK3, respectively [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $598 | Inquiry | Inquiry | |
| 10 mg | $954 | Inquiry | Inquiry |
| Description | MRIA9, an ATP-competitive inhibitor targeting pan Salt-Inducible Kinases (SIK) and PAK2/3, demonstrates IC50 values of 516 nM, 180 nM, and 127 nM for SIK1, SIK2, and SIK3, respectively [1]. |
| In vitro | MRIA9 (5 μM) enhances sensitivity to paclitaxel in SKOV3 cells by inducing pronounced apoptosis[1]. In combination with paclitaxel (2 nM), MRIA9 significantly increases cell death in HeLa cells[1]. MRIA9 strongly impedes centrosome function, mispositions mitotic spindles in ovarian cancer cell lines, prevents centrosome disjunction during the late G2 phase, and sensitizes ovarian cancer cells and patient-derived 3D-spheroids to paclitaxel[2]. |
| In vivo | MRIA9 exhibits high oral bioavailability (F = 75-80%)[1]. |
| Molecular Weight | 496.92 |
| Formula | C24H22ClFN6O3 |
| Cas No. | 2750707-05-0 |
| Smiles | C(N1C=2C(C=C(C1=O)C3=C(Cl)C=C(C=C3)C4=C(F)C=CC=N4)=CN=C(NC)N2)[C@@H]5OC[C@@H](N)CO5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.